Temporal echocardiographic assessment of pulmonary hypertension in idiopathic pulmonary fibrosis patients treated with nintedanib with or without oxygen therapy

BACKGROUND: Nintedanib is an inhibitor of receptor tyrosine kinases, including vascular endothelial growth factor receptor, but its effects on pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) patients with chronic hypoxia were unclear. METHODS: This study included a nintedanib pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahara, Masahiro, Oda, Keishi, Yamasaki, Kei, Kawaguchi, Takako, Sennari, Konomi, Noguchi, Shingo, Sakamoto, Noriho, Kawanami, Toshinori, Mukae, Hiroshi, Yatera, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704493/
https://www.ncbi.nlm.nih.gov/pubmed/31438928
http://dx.doi.org/10.1186/s12890-019-0918-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704493/
https://www.ncbi.nlm.nih.gov/pubmed/31438928
http://dx.doi.org/10.1186/s12890-019-0918-3

Ejemplares similares